Home BioCryst Pharmaceuticals

BioCryst Pharmaceuticals

In operation
Post-IPO Round
Disease Drug Developer
Basic
Enterprise Profile

Basic Information

BioCryst Pharmaceuticals is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan and autoimmune diseases as well as antiviral drugs. Its most advanced candidate drug is the antiviral Peramivir, which has been approved in Japan, South Korea, and China.
BioCryst Pharmaceuticals, Inc.
NorthCarolina,United States of America
101~500 people
January 01, 1986
info@biocryst.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Immunological Techniques Antibacterial/Antiviral Technology
Concept
Immune System Diseases Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs